TGFB1 and heart disorder: Furthermore, we demonstrated that these beneficial properties are most likely mediated by suppression of CTGF and its downstream signaling pathways, MAPK and TGF-β/Smad signaling, which are attractive targets for the prevention and/or treatment of cardiac diseases.